CEO Vlog: A Patient’s Story December 14, 2015 CEO Mark Capone tells the story of one patient and how genetic testing might have saved her life, as well as how it impacted the life of her daughter. "T... Continue Reading
CEO Vlog: Our Company Culture November 20, 2015 CEO Mark Capone describes the unique Myriad culture and what the "DNA of a Myriadian" means to us. "We recognize that every single thing we do every day, ther... Continue Reading
CEO Vlog: The Golden Era of Molecular Diagnostics November 12, 2015 CEO Mark Capone looks at the pioneering role Myriad is playing a as we enter the golden era of molecular diagnostics and what he envisions for our future. "In ... Continue Reading
CEO VLOG: Myriad’s Mission November 4, 2015 iframe { border: 1px solid #e4e5e6; } .pull-right.blog-single{ float:none !important } CEO Mark Capone talks about our mission, which is to answer patients' fo... Continue Reading
CEO VLOG: Myriad’s Vision October 21, 2015 iframe { border: 1px solid #e4e5e6; } .pull-right.blog-single{ float:none !important } CEO Mark Capone describes the Myriad Vision and what it means to u... Continue Reading
Team Myriad Raises Funds for the ACS Making Strides Against Breast Cancer Walk October 12, 2015 Myriadians are passionate about saving and improving the lives of patients worldwide with our breakthrough molecular diagnostic tests. That commitment extends b... Continue Reading
CEO VLOG: When Decisions Matter September 11, 2015 iframe { border: 1px solid #e4e5e6; } .pull-right.blog-single{ float:none !important } CEO Mark Capone talks about why patients and physicians choose Myr... Continue Reading
Myriad’s logo, transformed… September 11, 2015 Myriad has changed a lot over the past 20 years. We’ve gone from being a single product company in just the United States to a company with 15 products o... Continue Reading
Myriad Believes In Corporate Giving August 17, 2015 At Myriad, corporate responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests acros... Continue Reading
Medicare Covers Prolaris Genetic Test for Low-Risk Prostate Cancer August 13, 2015 On August 13, 2015, Medicare approved coverage of the Prolaris® test for men diagnosed with low-risk and very low-risk prostate cancer. The decision is the cul... Continue Reading
The Importance of Companion Diagnostics in Cancer and Beyond June 1, 2015 It’s been wonderful to watch the evolution of medicine over the course of my career. Twenty years ago, when I finished my training in gynecologic oncology (th... Continue Reading
My Personalized Journey with Ovarian Cancer May 4, 2015 Looking back, my journey with cancer really began when I was 40, a year after my paternal grandmother passed away. That was about the same time I first started ... Continue Reading